BioNxt Solutions扩大了针对增长市场的自发免疫疾病药物供应技术。 BioNxt Solutions expands drug delivery tech for autoimmune diseases, targeting growth markets.

BioNxt Solutions Inc.正在扩大其药物运送技术,重点是诸如MS、MG、LN和RA等自发性免疫疾病,使用亚语言、中转和口服系统。 BioNxt Solutions Inc. is expanding its drug delivery technologies, focusing on autoimmune diseases like MS, MG, LN, and RA, using sublingual, transdermal, and oral systems. 该公司还在为长寿市场开发产品,旨在改善患者的合规情况,并解决未得到满足的医疗需求。 The company is also developing products for the longevity market, aiming to improve patient compliance and address unmet medical needs. 这些条件的全球市场预计到2033年将大幅增长。 The global markets for these conditions are projected to grow significantly by 2033.